American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$318M |
| 2 |
US Bancorp
USB
|
+$222M |
| 3 |
Microsoft
MSFT
|
+$201M |
| 4 |
Allstate
ALL
|
+$174M |
| 5 |
Newell Brands
NWL
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WR
Westar Energy Inc
WR
|
+$470M |
| 2 |
HAR
Harman International Industries
HAR
|
+$269M |
| 3 |
Sysco
SYY
|
+$264M |
| 4 |
Apple
AAPL
|
+$223M |
| 5 |
Signet Jewelers
SIG
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.44% |
| 2 | Financials | 13.22% |
| 3 | Technology | 11.14% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Industrials | 10.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BSTC
1001
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $2.25M | ﹤0.01% |
56,335
+20,979
| +59% | +$768K |
|
|
TSRO
1002
DELISTED
TESARO, Inc.
TSRO
| $2.25M | ﹤0.01% |
26,729
-5,779
| -18% | -$258K |
|
1003
Pacira BioSciences
PCRX
$945M
| $2.24M | ﹤0.01% |
66,391
+206
| +0.3% | +$10.1K |
|
1004
TriCo Bancshares
TCBK
$1.84B
| $2.24M | ﹤0.01% |
81,114
| – | – |
|
1005
Lexicon Pharmaceuticals
LXRX
$1.05B
| $2.19M | ﹤0.01% |
+152,914
| New | +$2.07M |
|
|
ARC
1006
DELISTED
ARC Document Solutions, Inc.
ARC
| $2.19M | ﹤0.01% |
561,634
-144,354
| -20% | -$588K |
|
|
SVU
1007
DELISTED
SUPERVALU Inc.
SVU
| $2.18M | ﹤0.01% |
66,103
+835
| +1% | +$28.7K |
|
|
TCF
1008
DELISTED
TCF Financial Corporation Common Stock
TCF
| $2.18M | ﹤0.01% |
58,550
+2,553
| +5% | +$96.7K |
|
|
CMD
1009
DELISTED
Cantel Medical Corporation
CMD
| $2.18M | ﹤0.01% |
31,724
-5,094
| -14% | -$351K |
|
|
PFPT
1010
DELISTED
Proofpoint, Inc.
PFPT
| $2.17M | ﹤0.01% |
34,376
-4,691
| -12% | -$268K |
|
1011
Novavax
NVAX
$1.31B
| $2.16M | ﹤0.01% |
14,852
-2,874
| -16% | -$329K |
|
1012
Curtiss-Wright
CW
$26.7B
| $2.15M | ﹤0.01% |
25,491
+1,347
| +6% | +$108K |
|
1013
Titan Machinery
TITN
$431M
| $2.14M | ﹤0.01% |
191,855
-47,085
| -20% | -$541K |
|
|
PPBI
1014
DELISTED
Pacific Premier Bancorp
PPBI
| $2.13M | ﹤0.01% |
+88,870
| New | +$2.06M |
|
|
CAVM
1015
DELISTED
Cavium, Inc.
CAVM
| $2.13M | ﹤0.01% |
55,100
-16,391
| -23% | -$811K |
|
|
MWW
1016
DELISTED
Monster Worldwide Inc
MWW
| $2.1M | ﹤0.01% |
880,664
+2,364
| +0.3% | +$6.77K |
|
1017
DMC Global
BOOM
$155M
| $2.1M | ﹤0.01% |
195,135
-354,061
| -64% | -$3.33M |
|
|
RDUS
1018
DELISTED
Radius Health, Inc.
RDUS
| $2.09M | ﹤0.01% |
56,944
-10,072
| -15% | -$356K |
|
|
SYNT
1019
DELISTED
Syntel Inc
SYNT
| $2.09M | ﹤0.01% |
46,217
+35,410
| +328% | +$1.6M |
|
1020
RPM International
RPM
$14.7B
| $2.04M | ﹤0.01% |
+40,940
| New | +$2.05M |
|
1021
Ultragenyx Pharmaceutical
RARE
$2.65B
| $2.03M | ﹤0.01% |
41,566
+3,874
| +10% | +$251K |
|
1022
iShares MSCI EAFE Value ETF
EFV
$30.1B
| $2.03M | ﹤0.01% |
47,300
-3,366
| -7% | -$152K |
|
|
RTN
1023
DELISTED
Raytheon Company
RTN
| $2.03M | ﹤0.01% |
14,911
+220
| +1% | +$28.7K |
|
1024
Jazz Pharmaceuticals
JAZZ
$16.2B
| $2.02M | ﹤0.01% |
14,290
-104,664
| -88% | -$15.4M |
|
1025
ATN International
ATNI
$478M
| $1.95M | ﹤0.01% |
+25,108
| New | +$1.85M |
|
Similar funds
American Century Companies's Q2 2016 Portfolio in Review
As of Q2 2016, American Century Companies held 1,473 positions worth $88B, up 2.7% from $85.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
American Century Companies's Q2 2016 filing shows 185 new, 535 increased, 524 reduced and 149 closed positions. Its largest new stake was S&P Global: 1,042,865 shares worth $112M. The largest sale was Westar Energy Inc, an estimated $470M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Financials and Technology.
- American Century Companies's largest Q2 2016 buy was S&P Global: 1,042,865 shares worth $112M.
- American Century Companies added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $318M increase.
- American Century Companies's biggest Q2 2016 reduction was Westar Energy Inc, cutting an estimated $470M.
- American Century Companies fully exited Harman International Industries in Q2 2016, selling an estimated $269M.
- American Century Companies's ten largest holdings make up 13% of its $88B portfolio in Q2 2016.
- American Century Companies opened 185 new positions and closed 149 in Q2 2016.
- American Century Companies's portfolio value rose 2.7% quarter-over-quarter to $88B.
Based on American Century Companies's 13F filing for Q2 2016, filed 26 Jul 2016.